2012中国医师杂志Requires access

Therapeutic effects of the losartan combined with atorvastatin on the patients with diabetic nephropathy

Jing Li

Open publisher page 0 citations

Abstract

Objective To investigate the therapeutic effects of the losartan combined with atorvastatin on patients with diabetic nephropathy (DN).Methods 122 patients with DN were randomly divided into two groups,61 cases in the control group were received conventional therapy and added the losartan,61 cases in the observation group were treated by atorvastatin on the basis of the control group.The treatment time was 12weeks for each group.After 12 weeks,the systolic blood pressure (SBP),diastolic blood pressure (DBP),triglycerides (TG),total cholesterol (TC),low-density lipoprotein cholesterol (LDL-C),high density lipoprotein cholesterol (HDL-C),fasting blood glucose (FBG),urinary albumin excretion rate (UAER),serum creatinine (Scr),and glycosylated hemoglobin (HbAIc) were measured.Results The total effective rate was 93.44% in the observation group,and 75.41% in the control group,with a statistically significant difference between two groups (x2 =7.54,P < 0.01).After 12 weeks,the SBP and DBP were all changed more than before,DBP decreased more significantly (SBP:t =16.25,17.34,P <0.01 ;DBP:t =18.10,17.04,P <0.01); FBG,UAER,and HbAlc in the control group were significantly reduced (P < 0.05) ; the TG,TC,LDL,-C HDL,-CFBG,UAER,Scr,and HbAlc of the observed group were significantly reduced more,too.TG,TC,UAER,and Scr of the observed group were significantly lower than the control group (P < 0.05).Conclusions The losartan combined with atorvastatin that were used to treat patients with DN can reduce the urine albumin and protect the renal function. Key words: Losartan/therapeutic use ;  Heptanoic acids/therapeutic use ;  Pyrroles/therapeutic use ;  Diabetic nephropathies/drug therapy

About this research paper

What this paper is about

Objective To investigate the therapeutic effects of the losartan combined with atorvastatin on patients with diabetic nephropathy (DN).Methods 122 patients with DN were randomly divided into two groups,61 cases in the control group were received conventional therapy and added the losartan,61 cases in the observation group were treated by atorvastatin on the basis of the control group.The treatment time was 12weeks for each group.After 12 weeks,the systolic blood pressure (SBP),diastolic blood pressure (DBP),triglycerides (TG),total cholesterol (TC),low-density lipoprotein cholesterol (LDL-C),high density lipoprotein cholesterol (HDL-C),fasting blood glucose (FBG),urinary albumin excretion rate (UAER),serum creatinine (Scr),and glycosylated hemoglobin (HbAIc) were measured.Results The total effective rate was 93.44% in the observation group,and 75.41% in the control group,with a statistically significant difference between two groups (x2 =7.54,P < 0.01).After 12 weeks,the SBP and DBP were all changed more than before,DBP decreased more significantly (SBP:t =16.25,17.34,P <0.01 ;DBP:t =18.10,17.04,P <0.01); FBG,UAER,and HbAlc in the control group were significantly reduced (P < 0.05) ; the TG,TC,LDL,-C HDL,-CFBG,UAER,Scr,and HbAlc of the observed group were significantly reduced more,too.TG,TC,UAER,and Scr of the observed group were significantly lower than the control group (P < 0.05).Conclusions The losartan combined with atorvastatin that were used to treat patients with DN can reduce the urine albumin and protect the renal function. Key words: Losartan/therapeutic use ;  Heptanoic acids/therapeutic use ;  Pyrroles/therapeutic use ;  Diabetic nephropathies/drug therapy

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the therapeutic effects of the losartan combined with atorvastatin on patients with diabetic nephropathy (DN).Methods 122 patients with DN were randomly divided into two groups,61 cases in the control group were received conventional therapy and added the losartan,61 cases in the observation group were treated by atorvastatin on the basis of the control group.The treatment time was 12weeks for each group.After 12 weeks,the systolic blood pressure (SBP),diastolic blood pressure (DBP),triglycerides (TG),total cholesterol (TC),low-density lipoprotein cholesterol (LDL-C),high density lipoprotein cholesterol (HDL-C),fasting blood glucose (FBG),urinary albumin excretion rate (UAER),serum creatinine (Scr),and glycosylated hemoglobin (HbAIc) were measured.Results The total effective rate was 93.44% in the observation group,and 75.41% in the control group,with a statistically significant difference between two groups (x2 =7.54,P < 0.01).After 12 weeks,the SBP and DBP were all changed more than before,DBP decreased more significantly (SBP:t =16.25,17.34,P <0.01 ;DBP:t =18.10,17.04,P <0.01); FBG,UAER,and HbAlc in the control group were significantly reduced (P < 0.05) ; the TG,TC,LDL,-C HDL,-CFBG,UAER,Scr,and HbAlc of the observed group were significantly reduced more,too.TG,TC,UAER,and Scr of the observed group were significantly lower than the control group (P < 0.05).Conclusions The losartan combined with atorvastatin that were used to treat patients with DN can reduce the urine albumin and protect the renal function. Key words: Losartan/therapeutic use ;  Heptanoic acids/therapeutic use ;  Pyrroles/therapeutic use ;  Diabetic nephropathies/drug therapy

Key concepts: Losartan, Atorvastatin, Diabetic nephropathy, Internal medicine, Endocrinology, Medicine, Blood pressure, Urology

Related papers

Back to paper searchBrowse research topicsOriginal source
Therapeutic effects of the losartan combined with atorvastatin on the patients with diabetic nephropathy — Research Paper | ScholarLens